<DOC>
	<DOC>NCT00683618</DOC>
	<brief_summary>This trial is to compare the efficacy, safety and tolerability of Rosuvastatin with Atorvastatin by assessing the change of LDL-C in patients with hypercholesterolemia and history of coronary heart disease (CHD) or risk equivalent, or a 10 year CHD risk of no less than 10%, following 6-week treatment and a possible 6 week extension treatment.</brief_summary>
	<brief_title>Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Treated for or diagnosed hypercholesterolemia or have had a high risk with hypercholesterolemia LDLC between 3.36mmol/L and 6.5 mmol/L if not treated with statin or between 2.6mmol/L and 4.14 mmol/L Fasting triglyceride less than 4.52mmol/L History of statin induced myopathy Unstable or uncontrolled cardiovascular diseases Familial dysbetalipoproteinemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>HMG-CoA</keyword>
	<keyword>LDL-C</keyword>
	<keyword>CHD</keyword>
</DOC>